EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteolytic Activities and Immunological Effects of Light Chains of Botulinum Neurotoxin A1, A2 and A3 Subtypes

Yiying Liao, Xin Hu, Jingrong Wang iD, Jiansheng Lu, Shuo Yu, Yunzhou Yu, Wenhui Wu iD

Toxins · 2025

DOI: 10.3390/toxins18010016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Yiying Liao und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Botulism. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Botulinum neurotoxin serotype A (BoNT/A) is the most potent known neurotoxin. While its light chain (LC) catalytic domain is a prime target for next-generation vaccines and therapeutics, the functional differences among BoNT/A subtype LCs (A1, A2, A3) remain to be definitively characterized, despite notable sequence variation. This work aimed to systematically compare the proteolytic activity and immunoprotective efficacy of recombinant BoNT/A1-LC, A2-LC, and A3-LC. Recombinant A1-LC-His, A2-LC-His, A3-LC-His, and A3-LC-Twin-Strep proteins were expressed in Escherichia coli (E. coli) and purified with affinity chromatography. Their proteolytic activity was assessed via in vitro SNAP-25 cleavage assays. The protective potency of these antigens was evaluated in a mouse model. In vitro cleavage assays revealed a substrate cleavage efficiency order of A2-LC > A1-LC > A3-LC. In vivo, both A1-LC and A2-LC immunization conferred robust, broad protection against high-dose challenges with all three toxin subtypes. In stark contrast, A3-LC provided only minimal protection against its homologous toxin and none against heterologous subtypes. Crucially, the functional deficit of A3-LC was confirmed to be an intrinsic property, as the A3-LC-TS variant, designed to exclude tag-specific interference, exhibited comparable low efficacy. According to structural research, A3-LC’s compromised function may be caused by a four-amino-acid loss. The inferior performance of A3-LC is inherent to its primary structure. This work identified A1-LC or A2-LC as the potential proteolytic activity molecule and vaccine antigen by demonstrating functional differences among BoNT/A subtype LCs. These findings provide crucial insights for developing subtype-specific countermeasures against botulism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ABotulismAnimalsProteolysisMiceFemaleRecombinant ProteinsSynaptosomal-Associated Protein 25

Stichwörter der Autor:innen

SNAP-25botulinum neurotoxinlight chainprotective immunityproteolytic activity

Substanzen

Botulinum Toxins, Type ARecombinant ProteinsSynaptosomal-Associated Protein 25

Autor:innen und Institutionen

  • College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
  • Academy of Military Medical Sciences, Beijing 100850, China.

ORCID-Profile: Jingrong Wang, Wenhui Wu

Zitieren

APA

Liao, Y., Hu, X., Wang, J., Lu, J., Yu, S., Yu, Y., & Wu, W. (2025). Proteolytic Activities and Immunological Effects of Light Chains of Botulinum Neurotoxin A1, A2 and A3 Subtypes. Toxins. https://doi.org/10.3390/toxins18010016

Vancouver

Liao Y, Hu X, Wang J, Lu J, Yu S, Yu Y, et al. Proteolytic Activities and Immunological Effects of Light Chains of Botulinum Neurotoxin A1, A2 and A3 Subtypes. Toxins. 2025. doi:10.3390/toxins18010016

BibTeX
@article{Liao2025,
  author = {Liao, Yiying and Hu, Xin and Wang, Jingrong and Lu, Jiansheng and Yu, Shuo and Yu, Yunzhou and Wu, Wenhui},
  title = {Proteolytic Activities and Immunological Effects of Light Chains of Botulinum Neurotoxin A1, A2 and A3 Subtypes},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins18010016}
}
Kostenlos starten →